PT Darya-Varia Laboratoria Tbk (IDX:DVLA)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
1,660.00
-20.00 (-1.19%)
Feb 9, 2026, 3:31 PM WIB
Market Cap1.86T +3.8%
Revenue (ttm)2.12T -0.5%
Net Income173.09B -10.7%
EPS154.55 -10.7%
Shares Out1.12B
PE Ratio10.74
Forward PEn/a
Dividend108.00 (6.43%)
Ex-Dividend DateOct 29, 2025
Volume205,100
Average Volume42,665
Open1,680.00
Previous Close1,680.00
Day's Range1,550.00 - 1,680.00
52-Week Range1,325.00 - 1,750.00
Beta-0.18
RSI58.49
Earnings DateMar 17, 2026

About IDX:DVLA

PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear... [Read more]

Sector Healthcare
Founded 1976
Employees 1,311
Stock Exchange Indonesia Stock Exchange
Ticker Symbol DVLA
Full Company Profile

Financial Performance

In 2024, IDX:DVLA's revenue was 2.09 trillion, an increase of 10.40% compared to the previous year's 1.89 trillion. Earnings were 156.15 billion, an increase of 6.70%.

Financial Statements